The study was limited by a low accrual rate but among the 23 patients who were randomized, patients receiving lisinopril had less cough, less shortness of breath, fewer symptoms from lung cancer, less dyspnea with both walking and climbing stairs, and better overall quality of life demonstrating the benefit of ace inhibitors in reducing symptoms of radiation-induced lung injury [110]. Here, ACE is linked to lung carcinoma.